Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Pregabalin versus tramadol for postoperative pain management in patients undergoing lumbar laminectomy: a randomized, double-blinded, placebo-controlled study.

Kumar KP, Kulkarni DK, Gurajala I, Gopinath R.

J Pain Res. 2013 Jun 24;6:471-8. doi: 10.2147/JPR.S43613. Print 2013.

2.

Effects of axonal ion channel dysfunction on quality of life in type 2 diabetes.

Kwai NC, Arnold R, Wickremaarachchi C, Lin CS, Poynten AM, Kiernan MC, Krishnan AV.

Diabetes Care. 2013 May;36(5):1272-7. doi: 10.2337/dc12-1310. Epub 2013 Feb 12.

3.

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain.

De Salas-Cansado M, Olivares JM, Alvarez E, Carrasco JL, Barrueta A, Rejas J.

Clinicoecon Outcomes Res. 2012;4:157-68. doi: 10.2147/CEOR.S31102. Epub 2012 Jun 13.

4.

Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats.

Yang JL, Xu B, Li SS, Zhang WS, Xu H, Deng XM, Zhang YQ.

Mol Brain. 2012 May 30;5:18. doi: 10.1186/1756-6606-5-18.

5.

The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice.

Acheson DT, Stein MB, Paulus MP, Geyer MA, Risbrough VB.

Neuropharmacology. 2012 Sep;63(3):480-5. doi: 10.1016/j.neuropharm.2012.04.018. Epub 2012 May 2.

6.

Determination of pregabalin in human plasma by electrospray ionisation tandem mass spectroscopy.

Shah GR, Ghosh C, Thaker BT.

J Adv Pharm Technol Res. 2010 Jul;1(3):354-7. doi: 10.4103/0110-5558.72423.

7.

Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: basic characterization and drug pharmacology.

Quintero JE, Pomerleau F, Huettl P, Johnson KW, Offord J, Gerhardt GA.

Brain Res. 2011 Jul 15;1401:1-9. doi: 10.1016/j.brainres.2011.05.025. Epub 2011 May 18.

8.

Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: role of voltage-sensitive Ca2+ α2δ-1 subunit.

Quintero JE, Dooley DJ, Pomerleau F, Huettl P, Gerhardt GA.

J Pharmacol Exp Ther. 2011 Jul;338(1):240-5. doi: 10.1124/jpet.110.178384. Epub 2011 Apr 4.

9.

The effects of intrathecal and systemic gabapentin on spinal substance P release.

Takasusuki T, Yaksh TL.

Anesth Analg. 2011 Apr;112(4):971-6. doi: 10.1213/ANE.0b013e31820f2a16. Epub 2011 Mar 8.

10.

Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy.

Shoji S, Suzuki M, Tomono Y, Bockbrader HN, Matsui S.

Br J Clin Pharmacol. 2011 Jul;72(1):63-76. doi: 10.1111/j.1365-2125.2011.03932.x.

11.

Characterization of the acute and persistent pain state present in K/BxN serum transfer arthritis.

Christianson CA, Corr M, Firestein GS, Mobargha A, Yaksh TL, Svensson CI.

Pain. 2010 Nov;151(2):394-403. doi: 10.1016/j.pain.2010.07.030. Epub 2010 Aug 23.

12.

A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.

Tzellos TG, Papazisis G, Toulis KA, Sardeli Ch, Kouvelas D.

Hippokratia. 2010 Apr;14(2):71-5.

13.

Oxycodone combinations for pain relief.

Raffa RB, Pergolizzi JV, Segarnick DJ, Tallarida RJ.

Drugs Today (Barc). 2010 Jun;46(6):379-98. doi: 10.1358/dot.2010.46.6.1470106. Review.

14.

Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate.

Kumar N, Laferriere A, Yu JS, Leavitt A, Coderre TJ.

J Neurochem. 2010 Apr;113(2):552-61. doi: 10.1111/j.1471-4159.2010.06625.x. Epub 2010 Jan 28.

15.

Preclinical and early clinical investigations related to monoaminergic pain modulation.

Bannister K, Bee LA, Dickenson AH.

Neurotherapeutics. 2009 Oct;6(4):703-12. doi: 10.1016/j.nurt.2009.07.009. Review.

16.

Protective effects of gabapentin on allodynia and alpha 2 delta 1-subunit of voltage-dependent calcium channel in spinal nerve-ligated rats.

Hahm TS, Ahn HJ, Bae CD, Kim HS, Lim SW, Cho HS, Lee SM, Sim WS, Kim JA, Gwak MS, Choi SJ.

J Korean Med Sci. 2009 Feb;24(1):146-51. doi: 10.3346/jkms.2009.24.1.146. Epub 2009 Feb 28.

17.

Gabapentin acts within the locus coeruleus to alleviate neuropathic pain.

Hayashida K, Obata H, Nakajima K, Eisenach JC.

Anesthesiology. 2008 Dec;109(6):1077-84. doi: 10.1097/ALN.0b013e31818dac9c.

18.

Cellular and behavioral interactions of gabapentin with alcohol dependence.

Roberto M, Gilpin NW, O'Dell LE, Cruz MT, Morse AC, Siggins GR, Koob GF.

J Neurosci. 2008 May 28;28(22):5762-71. doi: 10.1523/JNEUROSCI.0575-08.2008.

19.

Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin.

Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su TZ, Bramwell S, Corradini L, England S, Winks J, Kinloch RA, Hendrich J, Dolphin AC, Webb T, Williams D.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17537-42. Epub 2006 Nov 6.

20.

New Horizons in the development of antiepileptic drugs: Innovative strategies.

Löscher W, Schmidt D.

Epilepsy Res. 2006 Jun;69(3):183-272.

Supplemental Content

Support Center